More than two-thirds of deaths from ovarian cancer are attributable to high-grade serous carcinoma. In one particularly ...
RICHMOND, Va. (WRIC) — September is Ovarian Cancer Awareness Month, bringing a critical health conversation to the forefront. As the deadliest of all female reproductive system cancers, ovarian cancer ...
Ian C. Cook, MD, discusses the feasibility and benefits of adding bilateral salpingectomy to nongynecologic surgery.
A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...
Suvemcitug combined with chemotherapy significantly improved PFS and OS in platinum-resistant recurrent ovarian cancer, nearly doubling median PFS and extending median OS. The trial demonstrated ...
Ovarian cancer is one of the most common forms of cancer, a type that usually remains undiagnosed for a while in many ...
Stage 2 ovarian cancer is localized to the pelvis, with substages 2A and 2B indicating specific spread patterns. Diagnosis involves physical exams, imaging, blood tests, and biopsy to confirm cancer ...
Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 ...
NICE has proposed age-based CA125 thresholds to improve early ovarian cancer detection while reducing unnecessary scans in ...
Cancer can throw a lot your way. Now it’s time to fight back. September is Ovarian Cancer Awareness Month, and there are plenty of ways to share your story and make your voice heard. “People lose so ...
In Ovarian Cancer, Interval Debulking Surgery Leads to Fewer Complications, Does Not Affect Survival
In this systematic review and meta-analysis, researchers examined outcomes among advanced ovarian cancer patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback